Anti-cytotoxic T-lymphocyte-associated antigen-4 monoclonal antibody quavonlimab in combination with pembrolizumab: Safety and efficacy from a phase I study in previously treated extensive-stage small cell lung cancer

Cho, BC; Yoh, K; Perets, R; Nagrial, A; Spigel, DR; Gutierrez, M; Kim, DW; Kotasek, D; Rasco, D; Niu, JX; Satouchi, M; Ahn, MJ; Lee, DH; Maurice-Dror, C; Siddiqi, S; Ren, YX; Altura, RA; Bar, J

Cho, BC (corresponding author), Yonsei Canc Ctr, 50-1 Yonsei Ro Sinchon Dong, Seoul 03722, South Korea.

LUNG CANCER, 2021; 159 (): 162

Abstract

Objectives: This first-in-human phase I study (NCT03179436) investigated anti-cytotoxic T-lymphocyte -associated protein 4 monoclonal antibody quavonl......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索